The role of combined drugs (fixed-dose combination pills) in the therapy of arterial hypertension

Lucyna Woźnicka; Anna Posadzy-Małaczyńska

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Abstracting and indexing Contact Instructions for authors

3/2009
vol. 12

Send email

Copy url:

abstract:

The role of combined drugs (fixed-dose combination pills) in the therapy of arterial hypertension

Lucyna Woźnicka

,

Anna Posadzy-Małaczyńska

Przew Lek 2009; 3: 58-69

Online publish date: 2009/08/03

View full text Get citation

Most patients with hypertension require more than a single antihypertensive agent, particularly if they have comorbid conditions. Combination therapy of hypertension with fixed-dose combination pills is required by most patients with hypertension to reach target blood pressure. In many cases, combination therapy improves rates of blood pressure control and requires less time to achieve target blood pressure with equivalent or better tolerability than higher-dose monotherapy. Additional benefits may include cost savings and better compliance. Large clinical trials performed in the last few years prove that combined therapy of essential hypertension has reached a secure position lately. Combined drug regimens are increasingly widely available in the pharmaceutical market – as a direct effect of information acquired from multicentre trials. Fixed-dose combination pills may in the near future become a basic part of treatment in many hypertensive patients.

keywords:

The role of combined drugs (fixed-dose combination pills) in the therapy of arterial hypertension

Lucyna Woźnicka , Anna Posadzy-Małaczyńska

hypertension, clinical trials, combined drugs (fixed-dose combination pills)

Lucyna Woźnicka

,

Anna Posadzy-Małaczyńska